Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing
BioPharm
Sponsored by Cytiva
Biopharma Trends
Upstream
Downstream
Regulatory/QbD
Articles
Subscribe to Enews
Share This Page
Email
Facebook
Twitter
September 23, 2021
Increasing mRNA Capabilities and Capacity for Growing Market Needs
Cytiva
Click here to read more >>
The success of the mRNA vaccine market is fueling high demand for mRNA, resulting in a critical need to address the manufacturing bottlenecks.
Related Content
Novavax Reports on Two Vaccine Efficacy Studies
Genetic Vaccine Platforms Demonstrate Their Potential
mRNA Therapeutics and Vaccines – Key Process Considerations
mRNA Global Alliance Tests the Waters at BIO
Can Vaccine Development Be Safely Accelerated?
See All Articles…
Click here to read more >>